An Ultralong-Acting Tenofovir ProTide Nanoformulation Achieves Monthslong HBV Suppression

A single intramuscular injection of NM1TFV, but not NTAF, demonstrated monthslong antiviral activities in both hepatitis B virus-transgenic and human hepatocyte transplanted mice.